3S Pharmaceuticals India Private Limited

3S Pharmaceuticals India Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U51909MH2021PTC370327 Incorporated 26 October 2021 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME
Data last updated
Revenue · FY 2024
₹16.32 Cr
▼ 11% YoY
Net profit · FY 2024
₹2.87 Cr
Net margin 17.6%
EBITDA · FY 2024
₹3.87 Cr
EBITDA margin 23.7%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About 3S Pharmaceuticals India Private Limited

Data last updated:

3S Pharmaceuticals India Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 October 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2021PTC370327. Its GSTIN is 27AABCZ8412F1ZA (Maharashtra).

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Piyansh Omprakash Mantry (Managing Director) and Omprakash Shankarlal Mantry.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A3 Bonanza Ind Estate A C Road Ashok Nagar Kandivali East, Mumbai, Maharashtra, India – 400101.

As per the financials filed for FY 2024, the company reported a revenue of ₹16.32 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹2.87 Cr (net margin 17.6%) and EBITDA of ₹3.87 Cr (EBITDA margin 23.7%).

3S Pharmaceuticals India Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-18-0146170).

Company details

CIN U51909MH2021PTC370327
Registration Number 370327
Incorporation Date 26 October 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification MSME
Udyam Registration UDYAM-MH-18-0146170

Recognitions & Rankings of 3S Pharmaceuticals India

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-MH-18-0146170

Contact details

3S Pharmaceuticals India Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    A3 Bonanza Ind Estate A C Road Ashok Nagar Kandivali East, Mumbai, Maharashtra, India – 400101
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of 3S Pharmaceuticals India Private Limited, buy the company report.

Comprehensive company report
3S Pharmaceuticals India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of 3S Pharmaceuticals India is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of 3S Pharmaceuticals India Private Limited, buy the company report.

Financials of 3S Pharmaceuticals India Private Limited

FY 2025 filings available

3S Pharmaceuticals India Private Limited reported revenue of ₹16.32 Cr (down 11% YoY) for FY 2024.

Revenue · FY 2024
₹16.32 Cr ▼ 11%
Net profit · FY 2024
₹2.87 Cr margin 17.6%
EBITDA · FY 2024
₹3.87 Cr margin 23.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 11%
EBITDA CAGR growth
1 year
▼ 22%

Revenue fell 11% in the latest year. EBITDA fell 22% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.87 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.87 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin23.7%
Net Profit Margin17.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of 3S Pharmaceuticals India Private Limited, buy the company report.

Board of directors of 3S Pharmaceuticals India Private Limited

3S Pharmaceuticals India has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Piyansh Omprakash MantryManaging Director26 Oct 20215 Years 0 MonthsCurrent
Omprakash Shankarlal MantryDirector26 Oct 20215 Years 0 MonthsCurrent

Peer comparison

3S Pharmaceuticals India Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Zanacea Biotec Private Limited₹16.37 Cr (FY 2025)4.0%Sikar, Rajasthan, India
Vignaharta Enterprises Private Limited₹16.36 Cr (FY 2025)52.0%Mohali, Punjab, India
Raishahib Gangaram Chowdhury & Sons Co Pvt Ltd₹16.35 Cr (FY 2025)25.0%Assam, India
3S Pharmaceuticals India Private Limitedthis company₹16.32 Cr (FY 2024)₹2.87 Cr17.6%-11.0%Mumbai, Maharashtra, India
Osb Agencies Private Limited₹16.24 Cr (FY 2025)22.0%Delhi, India
Gupta Medicare Pharmaceuticals Private Limited₹16.23 Cr (FY 2025)20.0%Panchkula, Haryana, India

To see the full peer comparison of 3S Pharmaceuticals India Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for 3S Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

3S Pharmaceuticals India Private Limited has 1 active EPFO establishment as of Apr 07, 2024.

Active EPFO establishments
1

GST

3S Pharmaceuticals India has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AABCZ8412F1ZAMaharashtraActive17 Nov 2021

To see the full GST registrations and return filing status of 3S Pharmaceuticals India Private Limited, buy the company report.

Recent activity

3S Pharmaceuticals India Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Omprakash Shankarlal Mantry was appointed as Director on 26 Oct 2021.

AGM
3S Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
3S Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Omprakash Shankarlal Mantry was appointed as Director.
Appointed
Piyansh Omprakash Mantry was appointed as Managing Director.
Incorporation
26 Oct 2021
3S Pharmaceuticals India Private Limited was registered on 26 Oct 2021 with Roc Mumbai & aged 5 years 14 days as per MCA records.

Frequently asked questions

3S Pharmaceuticals India is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 October 2021 (5+ years old) and is registered under CIN U51909MH2021PTC370327.

3S Pharmaceuticals India has 2 current directors:

The latest financial statements of 3S Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The GSTIN of 3S Pharmaceuticals India is 27AABCZ8412F1ZA, registered in Maharashtra.

The CIN (Corporate Identification Number) of 3S Pharmaceuticals India is U51909MH2021PTC370327. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

3S Pharmaceuticals India was incorporated on 26 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of 3S Pharmaceuticals India by revenue are Zanacea Biotec Private Limited, Vignaharta Enterprises Private Limited, Raishahib Gangaram Chowdhury & Sons Co Pvt Ltd, Osb Agencies Private Limited, Gupta Medicare Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Omprakash Shankarlal Mantry was appointed as Director on 26 Oct 2021. Piyansh Omprakash Mantry was appointed as Managing Director on 26 Oct 2021.

Yes, 3S Pharmaceuticals India is registered as an MSME under Udyam registration (number: UDYAM-MH-18-0146170).

The registered office of 3S Pharmaceuticals India is at A3 Bonanza Ind Estate A C Road Ashok Nagar Kandivali East, Mumbai, Maharashtra, India – 400101.

3S Pharmaceuticals India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.